DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Saura C, Oliveira M, Feng YH. et al.
Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With >/= 2 HER2-Directed Regimens: Phase III NALA
Trial.
J Clin Oncol 2020;
38: 3138-3149
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.